Development of a Tailored Smoking Cessation Program for Individuals With HIV Infection in Washington, D.C.
Public ClinicalTrials.gov record NCT04594109. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Morbidity and mortality from smoking-related diseases among people living with HIV (PLWH) in the U.S. surpasses that due to HIV itself. Conventional smoking cessation treatments have not demonstrated strong efficacy among PLWH. The investigators conducted a pilot randomized controlled trial (RCT) to evaluate a tailored smoking cessation intervention based on the minority stress model, hypothesizing that behavioral counseling through this lens would enhance cessation. The investigators compared standard of care counseling (SOC) to a tailored intervention (TI) including one face-to-face counseling session incorporating cognitive behavioral therapy to build resilience, and 30 days of 2-way text messaging.
Study identification
- NCT ID
- NCT04594109
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 25 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 29, 2017
- Primary completion
- Jan 28, 2018
- Completion
- Jan 29, 2018
- Last update posted
- Apr 18, 2023
2017 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Truth Initiative | Washington D.C. | District of Columbia | 20001 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Tobacco Smoking trials
Other public records listing Tobacco Smoking. Sorted by last update posted; newest first. Not a recommendation.
- NCT07743710: The SMOKE Telehealth Study Recruiting
- NCT07020273: CONNECT Cancer Survivors With Tobacco Treatment Active, not recruiting
- NCT07129590: Trauma-Informed Care for Smoking Cessation for Pregnancy Recruiting
- NCT06218056: Cannabidiol for Reducing Cigarette Use Recruiting
- NCT07398443: Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults Recruiting
- NCT05445804: Oral Cannabidiol for Tobacco Cessation Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04594109, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04594109 live on ClinicalTrials.gov.